Comparison of Different Automated Office Blood Pressure Measurement Devices: Evidence of Nonequivalence and Clinical Implications

Canadian Journal of Cardiology

Volumn 33, Issue 12, 2017, Pages 1639-1644

  Rinfret, Félix ^a,b   Cloutier, Lyne ^c   Wistaff, Robert ^a   Birnbaum, Leora M ^a   Ng Cheong, Nathalie ^a   Laskine, Mikhael ^a,d   Roederer, Ghislaine ^a   Van Nguyen, Paul ^a   Bertrand, Michel ^a   Rabasa Lhoret, Remi ^a,b   Dufour, Robert ^a   Lamarre Cliche, Maxime ^a  

^a CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c UNIVERSITÉ DU QUÉBEC À TROIS RIVIÈRES   (Canada)

^d CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT;

AGED; ANTIHYPERTENSIVE THERAPY; ARM CIRCUMFERENCE; ARTICLE; AUTOMATION; BLOOD PRESSURE MEASUREMENT; BODY MASS; COMPARATIVE STUDY; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PARALLEL DESIGN; PROSPECTIVE STUDY; SYSTOLIC BLOOD PRESSURE; BLOOD PRESSURE; DEVICES; EQUIPMENT DESIGN; PATHOPHYSIOLOGY; PHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; REPRODUCIBILITY; SPHYGMOMANOMETER;

AGED; AUTOMATION; BLOOD PRESSURE; BLOOD PRESSURE DETERMINATION; EQUIPMENT DESIGN; FEMALE; HUMANS; HYPERTENSION; MALE; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; SPHYGMOMANOMETERS;

EID: 85035000720     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cjca.2017.09.011     Document Type: Article

References (22)

1. Forouzanfar, M.H., Alexander, L., Anderson, H.R., et al. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 386 (2015), 2287–2323.
2. Turnbull, F., Neal, B., Ninomiya, T., et al. Effects of different regimens to lower blood pressure on major cardiovascular events in older and younger adults: meta-analysis of randomised trials. BMJ 336 (2008), 1121–1123.
3. Ettehad, D., Emdin, C.A., Kiran, A., et al. Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis. Lancet 387 (2016), 957–967.
4. Myers, M.G., Valdivieso, M., Kiss, A., Use of automated office blood pressure measurement to reduce the white coat response. J Hypertens 27 (2009), 280–286.
5. Beckett, L., Godwin, M., The BpTRU automatic blood pressure monitor compared to 24 hour ambulatory blood pressure monitoring in the assessment of blood pressure in patients with hypertension. BMC Cardiovasc Disord, 5, 2005, 18.
6. Mattu, G.S., Perry, T.L. Jr., Wright, J.M., Comparison of the oscillometric blood pressure monitor (BPM-100(Beta) ) with the auscultatory mercury sphygmomanometer. Blood Pressure Monit 6 (2001), 153–159.
7. Wright, J.M., Mattu, G.S., Perry, T.L. Jr., et al. Validation of a new algorithm for the BPM-100 electronic oscillometric office blood pressure monitor. Blood Pressure Monit 6 (2001), 161–165.
8. Myers, M.G., Kaczorowski, J., Paterson, J.M., Dolovich, L., Tu, K., Thresholds for diagnosing hypertension based on automated office blood pressure measurements and cardiovascular risk. Hypertension 66 (2015), 489–495.
9. Wright, J.T. Jr., Williamson, J.D., Whelton, P.K., et al. A randomized trial of intensive versus standard blood-pressure Control. N Engl J Med 373 (2015), 2103–2116.
10. Leung, A.A., Nerenberg, K., Daskalopoulou, S.S., et al. Hypertension Canada's 2016 Canadian hypertension education program guidelines for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension. Can J Cardiol 32 (2016), 569–588.
11. Faul, F., Erdfelder, E., Lang, A.G., Buchner, A., G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods 39 (2007), 175–191.
12. Greiver, M., White, D., Kaplan, D.M., et al. Where should automated blood pressure measurements be taken? Pilot RCT of BpTRU measurements taken in private or nonprivate areas of a primary care office. Blood Pressure Monit 17 (2012), 137–138.
13. Armstrong, D., Matangi, M., Brouillard, D., Myers, M.G., Automated office blood pressure—being alone and not location is what matters most. Blood Pressure Monit 20 (2015), 204–208.
14. Myers, M.G., Valdivieso, M., Kiss, A., Tobe, S.W., Comparison of two automated sphygmomanometers for use in the office setting. Blood Pressure Monit 14 (2009), 45–47.
15. El Assaad, M.A., Topouchian, J.A., Darne, B.M., Asmar, R.G., Validation of the Omron HEM-907 device for blood pressure measurement. Blood Pressure Monit 7 (2002), 237–241.
16. Omboni, S., Riva, I., Giglio, A., et al. Validation of the Omron M5-I, R5-I and HEM-907 automated blood pressure monitors in elderly individuals according to the International Protocol of the European Society of Hypertension. Blood Pressure Monit 12 (2007), 233–242.
17. Ostchega, Y., Nwankwo, T., Sorlie, P.D., Wolz, M., Zipf, G., Assessing the validity of the Omron HEM-907XL oscillometric blood pressure measurement device in a National Survey environment. J Clin Hypertens 12 (2010), 22–28.
18. White, W.B., Anwar, Y.A., Evaluation of the overall efficacy of the Omron office digital blood pressure HEM-907 monitor in adults. Blood Pressure Monit 6 (2001), 107–110.
19. Drawz, P.E., Pajewski, N.M., Bates, J.T., et al. Effect of intensive versus standard clinic-based hypertension management on ambulatory blood pressure: results from the SPRINT (Systolic Blood Pressure Intervention Trial) ambulatory blood pressure study. Hypertension 69 (2017), 42–50.
20. Myers MG, Kaczorowski J. Office blood pressure is lower than awake ambulatory blood pressure at lower targets for treatment (e-pub ahead of print). J Clin Hypertens (Greenwich) https://doi.org/10.1111/jch.13090.
21. Omron Healthcare Inc. IntelliSense Blood Pressure Monitor Model HEM 907XL. Vol 2017.
22. BpTRU Medical Devices. Operator's Manual. Vol 20172014.